Contents
Academy · Checklists · AGREE Reporting Checklist
The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward.
The AGREE Reporting Checklist is a 23-item tool, mirroring AGREE II’s six domains, that tells the authors of a new clinical practice guideline what their report must disclose. It produces no quality score — only a record of what was reported and where.
Published by Melissa Brouwers, Kelvin Kerkvliet and Karen Spithoff for the AGREE Next Steps Consortium in the BMJ in 2016, the AGREE Reporting Checklist repurposes AGREE II’s six validated domains as reporting instructions for guideline authors, rather than a rating scale for appraisers. The two tools share a consortium and a domain structure, which is exactly why they are so often confused.
What it is
Brouwers MC, Kerkvliet K, Spithoff K, for the AGREE Next Steps Consortium. “The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines.” BMJ, 2016;352:i1152. Open access.
Journals and guideline developers had AGREE II to appraise a finished guideline’s development quality, but no dedicated tool telling authors, item by item, what a new guideline report needs to contain for that quality to be judgeable in the first place. The Reporting Checklist closes that gap, the same way CONSORT and STROBE do for trials and observational studies.
New clinical practice guidelines being written or finalised for publication — guideline development reports, not primary research studies, and not an appraisal of someone else’s existing guideline.
Is this the right tool?
Use it when
Guideline development groups and authors, while finalising the document before submission or public release. Journal editors and peer reviewers of guideline manuscripts use it as a submission requirement, the same way STROBE or CONSORT function for other study types.
Not the right tool when
Third parties wanting to judge the quality of an already-published guideline should use AGREE II, not this checklist — the Reporting Checklist has no rating scale and produces no quality score, only a record of whether information was disclosed. It also does not apply to primary clinical studies.
The checklist
23 items across the same six domains AGREE II uses, each written as a reporting instruction rather than a rating item.
Domain 1–3
| Item | What it requires |
|---|---|
| 1–3. Scope and purpose | State the guideline’s objectives, the health question(s) it addresses, and the population it applies to. |
| 4–6. Stakeholder involvement | List the development group with expertise and role, explain how the target population’s views were gathered, and identify the intended users. |
| 7–14. Rigour of development | Search methods, evidence-selection criteria, strengths and limitations of the evidence, how recommendations were formulated, benefits and harms, the link between evidence and recommendations, external review, and an updating procedure. |
Domain 4–6
| Item | What it requires |
|---|---|
| 15–17. Clarity of presentation | State the recommended action plainly, describe management options, and make key recommendations easy to find. |
| 18–21. Applicability | Facilitators and barriers to implementation, practical tools, resource implications, and monitoring or auditing criteria. |
| 22–23. Editorial independence | Name the funder and confirm no influence on content; confirm competing interests were declared and managed. |
Applying it, with the evidence
This checklist is younger than AGREE II (2016 vs 2010) and used at the authoring stage rather than post-publication appraisal, so it has not accumulated the same large-scale adherence literature. What research for this page did confirm is that real guideline submissions complete and publish it as supplementary material, cross-referencing each item to a specific manuscript page — exactly how the tool is meant to work.
Used by clinical-practice-guideline development groups across any specialty producing a new guideline for publication — oncology, nutrition and metabolic care, infectious disease and general internal-medicine guideline programmes — at the point of finalising the manuscript before submission, and by journals as a submission requirement.
In order
Where it goes right
With it — no verifiable example found
Our research for this page did not turn up a named, checkable published paper that explicitly credits this checklist for a well-reported study. Rather than invent one, we are saying so. If you know of one, the EQUATOR Network page for this guideline is the place such examples tend to get collected.
Common mistakes
- The single most consequential mistake is confusing this with AGREE II. Always name which of the two tools a piece of work used, and why.
- Domain 3 (rigour of development) is the weak point. It is the largest domain and the one the checklist’s own developers built it to close gaps in.
- Do not treat it as optional supporting material. Skipping it risks a guideline being later judged poorly by AGREE II appraisers simply because a sound process was never disclosed.
Where it falls short
Without it — no verifiable example found
We did not find a published audit naming specific papers that skipped this checklist. That is a gap in what is easy to find, not evidence that omission is rare.
Common questions
No. They are two separate, independently citable publications from the same consortium, sharing six domain names: AGREE II (CMAJ 2010) appraises an existing guideline’s quality; the AGREE Reporting Checklist (BMJ 2016) tells authors of a new guideline what to disclose.
As the submitting author, almost always the AGREE Reporting Checklist; AGREE II is normally completed by reviewers or appraisers, not by the authors themselves. Confirm against the specific journal’s instructions.
No. It only confirms information was disclosed, not that the underlying development process was rigorous. A guideline could fully report a weak process and still score poorly under AGREE II.
References and sources
- Brouwers MC, Kerkvliet K, Spithoff K, for the AGREE Next Steps Consortium. The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ, 2016;352:i1152. read 8 October 2026. doi.org/10.1136/bmj.i1152
- EQUATOR Network. The AGREE Reporting Checklist. read 8 October 2026. equator-network.org
Each source carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 8). The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward. Pubrica. https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/
Pubrica Academy. “The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward.” Pubrica, 8 Oct. 2026, pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/.
Pubrica Academy (2026) The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward. Pubrica. Available at: https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/ (Accessed: 15 October 2026).
Pubrica Academy. “The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward.” Pubrica. October 8, 2026. https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/
Pubrica Academy, ‘The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward’ (Pubrica, 8 October 2026) <https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/> accessed 15 October 2026.
Pubrica Academy. The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward. [Internet]. Pubrica; 2026 Oct 8 [cited 2026 Oct 15]. Available from: https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/
Pubrica Academy, “The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward,” Pubrica, Oct. 8, 2026. [Online]. Available: https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/
@misc{agree_clinical_practice_guidelines_che_2026,
author = {{Pubrica Academy}},
title = {The AGREE Reporting Checklist Is for Guideline Authors. AGREE II Is for Everyone Appraising Their Work Afterward},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/insights/checklist/agree-clinical-practice-guidelines-checklist/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Pubrica AcademyWritten and maintained by the subject matter experts of Pubrica who do this work. Articles are revised when the standard underneath them moves, and each one carries the date it was last checked.
How Pubrica helps
Pubrica’s guideline-writing team maps each of the 23 items to a page in the draft as the guideline is written, so the completed checklist is accurate rather than reconstructed the night before submission.